Biosante Pharmaceuticals Aktie
WKN DE: A1W15D / ISIN: US00182C1036
22.06.2022 13:05:51
|
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
ANI's Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
The current annual U.S. market for Clorazepate Dipotassium Tablets is approximately $25.8 million, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Biosante Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Biosante Pharmaceuticals Inc | 53,00 | 0,95% |
|